(ASND) Strategic Investment Report (ASND:CA) - news.stocktradersdaily.com
2 hours ago • Google News
Ascendis Pharma AS (ASND)
US$ 160.99-1.14%
Price Chart
Key Statistics
Market Cap
$ 9.77B
P/E Ratio
0.00
Revenue (TTM)
$ 368.7M
Volume
550.99K
52W High
$ 183.00
52W Low
$ 111.09
Dividend Yield
0.00%
Beta
0.40
Technicals
50-Day MA
157.6861
200-Day MA
140.0147
52 Week High
183
52 Week Low
111.09
About ASND
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally..
Employees
1017
Headquarters
Hellerup, Denmark
CEO
Mr. Jan Moller Mikkelsen
Latest News
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today - Benzinga
17 hours ago • Google News
fromis_9 confirm plans to release new album in June as five-piece - NME
2 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg